chrisvoncsefalvay/vaers-outcomes huggingface dataset:
red / pink Rash on upper arm below the injection site; Red / pink rash on the inside of the injection forearm; Red / pink rash on upper arm below the injection site; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (red / pink Rash on upper arm below the injection site), RASH (Red / pink rash on the inside of the injection forearm) and INJECTION SITE RASH (Red / pink rash on upper arm below the injection site) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 22-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Mar-2021, the patient experienced ERYTHEMA (red / pink Rash on upper arm below the injection site), RASH (Red / pink rash on the inside of the injection forearm) and INJECTION SITE RASH (Red / pink rash on upper arm below the injection site). At the time of the report, ERYTHEMA (red / pink Rash on upper arm below the injection site), RASH (Red / pink rash on the inside of the injection forearm) and INJECTION SITE RASH (Red / pink rash on upper arm below the injection site) outcome was unknown.            No Concomitant medications were provided No Treatment information provided
Experienced chest pain on patient left side from 11/22-11/28/21.  Visited ER on 11/28/21 and was diagnosed with costochondritis, treated with advil and rest.
No Adverse Reaction At Time of Administration. Patient's parents deny any adverse reaction at 3:00pm of 3/20/2017.
Croup like cough and severe wheezing, shortness of breath; took her to ER, administered 3 neb treatments, epi treatment, oral steroid, symptoms subsided, left ER without admittance at 3am.
severe muscle pain on injection site 10 days after getting dose.  i could barely move my left arm
Left arm swelling, red, area size of softball, itching, no fever. NKA food/medications. Note: FU phone call 4/29/05 no itching, swelling and redness gone.
Less than a week after my second vaccination shot, i noticed a tremor in my left pinky finger. This subsided after two weeks. It was replaced by muscle tremors all over. My physician has diagnosed them as "intentional tremors."  After some bloodwork, my physician concluded that hyperthyroidism was the cause of the tremors. However, in 2019 my thyroid functions were normal as determined by bloodwork.  However, since my tremors have started I have spoken to a number of people who have also had similar symptoms since receiving the Covid vaccination. It is my belief that the Covid vaccination may have adversely affected my thyroid and caused muscular tremors.
Patient is a 78 y.o. female patient of DO presented with abnormal labs.  Found to have hyperkalemia, tracheitis and Covid.    Tracheitis - resolved Acute on chronic respiratory failure - resolved Covid 19 virus infection - resolved WBC 12.04--10.88 Patient arrived in the ED via EMS on 15 L of blow-by oxygen.  Patient was discharged on 5 L about 10 days ago. Chest x-ray "mild bilateral perihilar airway wall thickening with surrounding streaky opacities" Large amount of thick mucus suctioned from trachea in the ER Inner cannula of trach removed and replaced in the ER Patient was then weaned to room air in the ED Sputum cultures --normal flora Appreciate ID input--Vancomycin d'ced. Completed course of Rocephin Completed course of Remdesivir and Decadron; now out of COVID isolation Appreciate Pulmonology input-- downsized trach to a Shiley 6 Pt doing well on 2L O2 at 100%, can likely wean to room air   Hyperkalemia - resolved Potassium is 6.1 No EKG changes; sinus bradycardia without QT prolongation Etiology unclear; not in renal failure, no inciting medications. May be related to hyperglycemia. Insulin/dextrose/Lasix given in the ER Follow-up potassium improved to 4.4     Transaminitis Elevated alk phos, AST, ALT Has been elevated in the past Avoid hepatotoxic agents Alk phos 120, AST 31, ALT 79 Consider rechecking outpatient  Type 2 diabetes Sliding scale insulin.  Continue Lantus 10 units Continue to monitor BG's and adjust insulin accordingly. Diabetic tube feeds Fair glycemic control   Anoxic brain injury History of CVA Status post tracheostomy Status post PEG placement Nutrition following for tube feeding Respiratory therapy for trach care  Speak valve per speech therapy   History of seizure-like activity Continue Keppra
Swollen upper arm, pain in arm radiating to neck, shoulder, arm and forearm.
At the time of the vaccine, I felt fine, soreness at the injection site but nothing. For days later, I began to feel, ill all over and could not get out of bed.  I had severe abdominal pain, aches and pains all over my body.  Particularly in places where I had pre existing conditions.  As the day progressed, I continued to have severe GI issues, could not eat (pain like food was stuck) heart burn, constipation (clamy like flu).  Shortness of breath, I could not walk far.  I took 3 trips to the ER where they treated for the abdominal spasms, UTI, and pain.  By the end of the week I had a slight fever.  I tested negative for COVID during that time.  For two weeks I was unable to eat, get out of bed.  I had several petite mal seizures.  If felt like my body was fighting the vaccine and the vaccine was attaching all of me weak or any preexisting conditions.  Eventually, after 3.5 weeks I was able to sit up, and walk. I still have shortness of breath, some fogginess,  Muscle strain, walking with a cane and a lump at the injection site.
moderate to severe fainting spell; tingling in legs and hands; profuse sweating; chills; This spontaneous case was reported by a consumer and describes the occurrence of SYNCOPE (moderate to severe fainting spell) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 03-Jun-2021 at 2:10 PM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Jun-2021, the patient experienced PARAESTHESIA (tingling in legs and hands), HYPERHIDROSIS (profuse sweating) and CHILLS (chills). On 04-Jun-2021 at 12:15 PM, the patient experienced SYNCOPE (moderate to severe fainting spell) (seriousness criterion medically significant). On 04-Jun-2021, SYNCOPE (moderate to severe fainting spell), HYPERHIDROSIS (profuse sweating) and CHILLS (chills) had resolved. At the time of the report, PARAESTHESIA (tingling in legs and hands) outcome was unknown.            It was reported the patient did not go to ER but did consider calling an ambulance if the initial part of the spell did not pass within another 30 minutes.  No treatment and concomitant medication information reported.  Company Comment : Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Starting at 7:30pm, approximately 6 hours after the vaccines were administered, baby began a shrill, high-pitch shriek. This shriek persisted for almost an hour while his parents tried to comfort their unconsolable baby. This cry/shriek was unlike anything heard from that child before. Additionally, in the days/weeks following receiving these vaccines, the child formed a rash which was later diagnosed as eczema by his pediatrician. The eczema started on the backs of his legs and slowly spread to his arms and face. Prior to vaccines, the child had perfectly clear skin with no history of skin rashes. The eczema has persisted since these vaccines.
Hospitalization: 11/6/2022 - 11/9/2022 (3 days) Presentation to the ED: syncopal episode. COVID + date: 11/6/22. Treatment: none, patient was asymptomatic. Discharge to: Home.
This case was reported by a physician via a GSK representative and described the occurrence of arm swollen in a child subject of unspecified gender who was vaccinated with combined KINRIX, (GlaxoSmithKline).  On an unspecified date the subject received unspecified dose of KINRIX (details unknown).  At an unspecified time after vaccination with KINRIX, the subject experienced arm swollen.  The subject was sent to an urgent care facility.  At the time of reporting the outcome of the event was unspecified.  There was no further information available.
I Got  right arm sore after few days second dose of CoVID19 vaccine and then 5,6 months later my  right arm  couldn?t lift  and visited orthopedic doctor in August 2021 then has been diagnosed as frozen  shoulder. I had corticosteroids injection immediately on the first orthopedic doctor office visit and had 2 and half months Physical therapy prescribed, currently right arm still not fully recovered.
Px experienced redness and swelling up to almost the elbow on 10/05/19 on her right arm where we administered the Pneumovax23 and was reported to us on 10/07/19. Px said she put ice on it and on the time it was reported it doesn't feel as hard anymore as the previous days. Px was asked if there were any other reactions besides the redness and swelling and she said it was a little itchy but not painful and no reaction on the other arm where we administered the Fluad. Advised px to continue to put ice and to take ibuprofen for swelling and diphenhydramine if it continues to itch. Followed up with px the following day 10/08/19 and px said swelling has gone down and she didn't take diphenhydramine but she took advil and everything was fine
arm is hurt but not much; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm is hurt but not much) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Mar-2021, the patient experienced PAIN IN EXTREMITY (arm is hurt but not much). At the time of the report, PAIN IN EXTREMITY (arm is hurt but not much) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       no concomitant medications are provided. treatment to the events not provided. patient planning to take his 2nd dose on 14-apr-2021.o right arm.
This resident received the J&J vaccine on August 19, 2021. On Saturday, August 21, 2021 she began exhibiting signs of altered mental status. It was discovered that she had a urinary tract infection and was started on Macrobid. Her physician gave the order to transport her to the emergency room for further evaluation and treatment. It was discovered during her ER evaluation that she had suffered a subacute evolving lacunar infarct in the right corona radiata. The hospital notified this nurse for VAERS reporting.
2nd day redness on arm and lots of pain; 3rd day lots pain to arm and lump and redness and back pain
I developed pectoral muscle myositis with severe pain and inflammation starting gradually around 24 hours after the vaccine. Redness and swelling lasted for 24 hours.  Forty eight hours after 8cm by 4cm ecchymosis appeared  in my axillary region around the lateral aspect of my left breast.
Pt c/o and called 05/06/05 @ 9:00 with redness, swelling, and tender to the touch, at injection site down to the middle of forearm. Pt see by MD TX with prednisone and doxycycline 250mg Q 6 Hx 7 D
Swelling in hands; Depressed; breaking out (rash) / 4-5 marks around left side of waist; joint swelling in hands and knuckles; Nasal Congestion; Runny Nose; Nose described as feeling thick and swollen; Nose swollen; This case was reported by a consumer via call center representative and described the occurrence of extensive swelling of vaccinated limb in a 71-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included zoledronic acid (Reclast) for an unknown indication.   The patient's past medical history included malignant neoplasm of abdomen (Cancer survivor tumor in abdomen at age 57). Concomitant products included vitamin d and Herpes zoster (Shingrix).   On 17th February 2020, the patient received the 2nd dose of Shingrix (intramuscular) 50 µg. On 5th October 2019, the patient started Reclast at an unknown dose and frequency. In May 2020, less than 3 months after receiving Shingrix, the patient experienced extensive swelling of vaccinated limb, depression, rash, swollen joints, nasal congestion, runny nose, nasal discomfort and nasal edema. The patient was treated with benadryl (nos) (Benadryl). The action taken with Reclast was unknown. On an unknown date, the outcome of the extensive swelling of vaccinated limb, nasal discomfort and nasal edema were unknown and the outcome of the depression and rash were recovering/resolving and the outcome of the swollen joints, nasal congestion and runny nose were not recovered/not resolved.   It was unknown if the reporter considered the extensive swelling of vaccinated limb, depression, rash, swollen joints, nasal congestion, runny nose, nasal discomfort and nasal edema to be related to Shingrix.  Additional details were provided as follows: In November 2019, the patient received 1st dose. The patient received 2nd dose in left arm. Around the first week in May consumer reports developing a runny nose with nasal congestion, joint swelling in hands and knuckles, breaking out (rash) in 4-5 areas around left side of waist, and feeling depressed. Nose described as feeling thick and swollen, Nose swollen and consumer reported about taking Benadryl which to help throughout the day but still bothersome.  Swelling in hands were to point where she was unable to remove ring from finger.  The consumer reported that the swelling might be due to Reclast bone IV infusion, which her infusion, or 5 out of 5, was administered on 5th October 2019.  The reporter stated that broke with 4 to 5 marks around left side of waist area around the same time her husband a small bout of shingles with no prior history of any shingles vaccine. Lastly, the consumer reported that feeling depressed due to the events listed and also being a cancer survivor where a tumor was found on her abdomen when she had just turned 57. Caller does not want to go through fighting cancer again or any more disease states.  She reported only prescription taken was Vitamin D. The reporter did consent to follow up. This case has been linked with case US2020AMR096108, reported by the same reporter; Sender's Comments:  US-GLAXOSMITHKLINE-US2020AMR096108:Same reporter
Stomach problems; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISCOMFORT (Stomach problems) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Aug-2021, the patient experienced ABDOMINAL DISCOMFORT (Stomach problems). At the time of the report, ABDOMINAL DISCOMFORT (Stomach problems) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported. No treatment history was reported.  Patient stated that she has exposed to people with active COVID-19 Disease. Patient also stated that the stomach problems which started has nothing to do with the vaccine.
Redness swelling and it was extremely hot and hard as a rock at injection area.  It did hurt really bad.
This spontaneous report was received from a pharmacist regarding a patient of unknown age and gender. Information on the concurrent condition, medical history and pertinent drug allergies of the patient were not reported. On 24-NOV-2015 at time- 19:55, the patient was vaccinated with improperly stored RECOMBIVAX HB lot # L016427 (expiry date, dose #, route, dose units and anatomical location were not specified). Concomitant medication was not reported. No adverse events were reported. The high temperature and low temperature at which the product was stored were 3.0 and 1.0 (units unspecified) respectively. There were no Product Quality Complaint (PQC) involved. This is one of several reports received from same reporter. Additional information has been requested.
COVID/had Covid positive diagnosis; COVID/had Covid positive diagnosis; A Lot Of Pain; MARKETING PROGRAM NOT AVAILABLE  This is a solicited report received from contactable reporter(s) (Consumer or other non HCP) for a sponsored program. The reporter is the patient. Other Case identifier(s): 22K-163-4232687-00 (Agency).  A 58 year-old female patient received bnt162b2 (BNT162B2), intramuscular, administration date 22Aug2021 (Batch/Lot number: unknown) at the age of 58 years as dose 3 (booster), single, intramuscular, administration date 21Apr2021 (Batch/Lot number: unknown) as dose 2, single and intramuscular, administration date 31Mar2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation; upadacitinib (RINVOQ), first regimen oral (Batch/Lot number: unknown) and second regimen oral from 31Jan2022 (Batch/Lot number: unknown) to 31Jan2022 for rheumatoid arthritis. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset Jan2022, outcome "unknown" and all described as "COVID/had Covid positive diagnosis"; PAIN (non-serious) with onset Jan2022, outcome "unknown", described as "A Lot Of Pain". The patient underwent the following laboratory tests and procedures: sars-cov-2 test: positive. The action taken for upadacitinib was temporarily withdrawn on 31Jan2022. The patient was started Rinvoq yesterday, had Covid positive diagnosis and in a lot of pain. She was off of Rinvoq per doctors orders for two weeks. Rinvoq stored with other medications in reminder holder, resolved with nurse ambassador. It was unknown if patient was enrolled in a COVID-19 Vaccine Trial. The events of "Rinvoq stored with other medications" and "in a lot of pain" were added.  Causality for RINVOQ(UPADACITINIB) The reporter's causality for the event(s) of Covid and Rinvoq stored with other medications with Rinvoq(Upadacitinib) was a reasonable possibility. the reporter's causality for the event(s) of in a lot of pain was not provided. Causality: COVID-19 (COVID-19): Causality as per reporter (Drug/Vaccine) : Possible.   The lot number for bnt162b2 was not provided and will be requested during follow up.; Sender's Comments: Based on temporal association, there is reasonable possibility of causal association between the Reported events and the suspect drug BNT162B2. The impact of this report on the benefit/risk profile of the Pfizer drug is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees, and Investigators, as appropriate.
Systemic: Chills-Mild, Systemic: Dizziness / Lightheadness-Medium, Systemic: Flushed / Sweating-Medium, Systemic: Headache-Mild, Systemic: Nausea-Mild, Additional Details: Stayed in waiting area for approximately 15-20 minutes - provided her with ice pack - she was clammy, dizzy, lightheaded and nauseous within 5 minutes of administration - called to check on her the following day and she was having headaches and trouble sleeping but feeling somewhat better
This spontaneous report was received from a registered nurse refers to a currently 14 year old female patient. There was no pertinent medical history and no drug reactions/allergies. On 22-JUN-1999 the patient started a series of vaccination with hepatitis B vaccine (recombinant) (manufacturer unknown) (dose, strength, anatomical location, lot, number off doses not reported) and completed the series on an unspecified date. There was no concomitant medication. The reporter stated that the patient had serologic  testing performed by unspecified physician on an unspecified date, after the series was completed and the result was negative for anti HB antibodies. No treatment was given for the event. The outcome of negative for anti HB antibodies was reported as not recovered/not resolved. The relatedness was not reported. Additional information has been requested.
Systemic: Seizure-Mild, Additional Details: patient was on flight with mom and developed a seizure 9 days after receiving seizure. Patient had no prior history of seizures. Seziure lasted no more than 5 minutes. luckily a few doctors and nurses were on flight and they handeled the situation.
Injection site - left deltoid within 2" upper arm became very hard and swollen, warm to touch, extremely painful with minimal relief from Motrin or Tylenol. Left axilla and lymph nodes also very red, swollen, warm, and painful. Sx lasted five days, before beginning to subside.
If a patient had first Shingrix shot in 2018 do they need to restart series?; This case was reported by a other health professional via  interactive digital media and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received in 2018).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The age at vaccination was not applicable to this report. Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination. The reporter wanted to know they need to restart series or not.  The follow up would not be possible as no contact details were available.
2 HOURS AFTER FLU VACCINE COMPLAINS OF MUSCLE SPASMS AND PAIN AT SITE OF INJECTION.
Narrative: Patient presented to occ health for COVID bivalent booster. He was administered COVID Pfizer monovalent booster instead of COVID Pfizer bivalent vaccine.
Ocular Migrane - distortion of partial field of vision in both eyes, just to left of center of field of view; distortion similar to what is seen on a digital television when the signal is degraded.  Most of the rest of the field of view appeared to be normal.  Condition last for up to 30 minutes.  Has repeated on occasion since, most recent, today 1/1/2021.
h/a w/in 12hr;t99.0;mental confusion;pt mom report pt hallucinated p/19AUG87 DTP hot & cold, jerking line mid sz, pt knew was ankle but didn't know what was doing;pt was very weak & worse out;high fever,talking out of head (hallucinating);